Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
174 Leser
Artikel bewerten:
(0)

ATLAS Group: Advancement in Software Technologies Enables Access to Healthcare for Billions Worldwide

LONDON, May 28, 2020 /PRNewswire/ -- ATLAS Group London, Ltd. (ATLAS) announced today it hit the latest milestone for its ICAS Platform having completed its virtual testing for ICAS and reaching its Proof of Concept target.

ATLAS Group's ICAS Platform is an end-to-end technology platform enabling rapid, high-quality healthcare facility delivery at fixed costs. Offering unique solutions in technology and design, ATLAS Group is expanding global reach of healthcare services at reduce costs - making access to quality healthcare a reality for communities around the world. The COVID-19 pandemic spotlights existing strains on healthcare systems around the world and the importance of investing in healthcare infrastructure. Using technology to leapfrog progress is needed now more than ever.

The ICAS Platform is an end-to-end technology platform enabling rapid delivery of high-quality healthcare facilities at a fixed cost. By offering unique solutions in technology and design, ICAS will expand the global reach of healthcare services and reduce costs - making better access to quality healthcare a reality for communities around the world.

The COVID-19 pandemic spotlights existing strains on healthcare systems around the world and the importance of investing in healthcare infrastructure. Using technology to leapfrog progress is needed now more than ever.

"We are excited that we have reached this important milestone," said ATLAS Co-Founder and CEO David Harper. "Through our engagement with customers, there is an emerging consensus that they are looking for innovative methods to develop their healthcare infrastructure, leaving costly and time-consuming traditional models behind. There is a real need for Smart, 'Fast Track' platforms like ICAS which can be used to deliver higher volumes at better value."

"We are also excited to be working with Bill Allen and his team at EvolveLAB," said David Harper. "They share our vision of making global healthcare more accessible, and we could not have found better partners for this journey."

Bill Allen, Founder and CEO of EvolveLAB, said, "We are so excited to be partnering with David and the ATLAS team. Generative Design makes so much sense for healthcare. The world needs better access to healthcare services, and we are leveraging the latest technologies to help get it to them. The full ICAS Platform is currently in development and our next milestone is beta. We are working full steam ahead and are pleased to see David and his team already utilizing parts of the Platform to their customers' benefit."

David Harper said, "Healthcare stakeholders simply don't have the time to wait several years for a hospital to be designed and built. Our platform is aimed at customers in both the public and private sectors seeking a higher quality product and better value from their capital investments. These are customers who have experienced the delays, conflict, disputes and poor quality associated with conventional project delivery models, and they are fed up with the status quo. Like us, they know the industry needs to take a giant leap forward, and ICAS is a giant leap."

Allen said, "The ICAS platform uses multiple BIM 2.0 and digital twin technologies leveraging Agile sorting algorithms including auto-routing of mechanical, electrical, and plumbing algorithms optimizing resources and allowing us to focus on the tools that matter most to ATLAS and its customers. ICAS allows customers to design, cost and plan the construction of healthcare projects easily and quickly enabling them to build high quality healthcare facilities that deliver the best patient care."

Maha Harper, Co-Founder and COO of ATLAS, said, "We are also excited to be a part of Oracle for Startups. The Oracle cloud will play a key role in our global strategy in bringing ICAS to remote communities around the world. Fifty percent of the global population don't have access to primary healthcare services. Our innovative products and solutions allow customers to redefine the way they design, schedule, and deliver healthcare projects helping to transform global health and fight deadly diseases."

About ATLAS Group London, Ltd.

Visit www.atlascontech.com for more information.

About EvolveLAB LLC

Visit www.evolvebim.com for more information.

Photo - https://mma.prnewswire.com/media/1172922/ATLAS_Group_ICAS.jpg
Logo - https://mma.prnewswire.com/media/1172923/ATLAS_Oracle_EvolveLAB_Logo.jpg

ATLAS Oracle EvolveLAB Logo

© 2020 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.